Stuart A. Lipton

Scripps Research Institute, La Jolla, La Jolla, CA, United States 
 Neurosciences University of California, San Diego, La Jolla, CA 
Neurodegenerative Disease
"Stuart Lipton"

Mean distance: 12.18 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Okamoto SI, Prikhodko O, Pina-Crespo J, et al. (2019) NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model. Neurobiology of Disease
Oh CK, Sultan A, Platzer J, et al. (2017) S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models. Cell Reports. 21: 2171-2182
Tu S, Akhtar MW, Escorihuela RM, et al. (2017) NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. Nature Communications. 8: 1488
Nagar S, Trudler D, McKercher SR, et al. (2017) Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. Investigative Ophthalmology & Visual Science. 58: 3741-3749
Nagar S, Noveral SM, Trudler D, et al. (2017) MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress. Proceedings of the National Academy of Sciences of the United States of America
Lipton SA, Rezaie T, Nutter A, et al. (2016) Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models. Cell Death & Disease. 7: e2499
Sunico CR, Sultan A, Nakamura T, et al. (2016) Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of America
Singec I, Crain AM, Hou J, et al. (2016) Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling. Stem Cell Reports
Sanz-Blasco S, Piña-Crespo JC, Zhang X, et al. (2016) Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes. Neuroreport
Lipton SA, Nordstedt C. (2016) Partnering with Big Pharma-What Academics Need to Know. Cell. 165: 512-5
See more...